Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 25,435,724
  • Shares Outstanding, K 384,865
  • Annual Sales, $ 4,662 M
  • Annual Income, $ 836,300 K
  • EBIT $ 912 M
  • EBITDA $ 1,164 M
  • 60-Month Beta 1.48
  • Price/Sales 5.52
  • Price/Cash Flow 24.14
  • Price/Book 9.49

Options Overview Details

View History
  • Implied Volatility 49.06% (+2.90%)
  • Historical Volatility 36.84%
  • IV Percentile 61%
  • IV Rank 42.74%
  • IV High 77.57% on 10/30/25
  • IV Low 27.78% on 08/05/25
  • Expected Move (DTE 6) 2.61 (4.19%)
  • Put/Call Vol Ratio 0.51
  • Today's Volume 4,316
  • Volume Avg (30-Day) 2,622
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 83,641
  • Open Int (30-Day) 100,456
  • Expected Range 59.64 to 64.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.47
  • Number of Estimates 10
  • High Estimate 0.53
  • Low Estimate 0.42
  • Prior Year 0.32
  • Growth Rate Est. (year over year) +46.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.99 +0.42%
on 03/27/26
73.91 -15.78%
on 03/02/26
-11.18 (-15.23%)
since 02/27/26
3-Month
61.99 +0.42%
on 03/27/26
75.97 -18.07%
on 01/22/26
-5.32 (-7.87%)
since 12/26/25
52-Week
54.11 +15.04%
on 11/07/25
89.98 -30.82%
on 07/30/25
-7.22 (-10.39%)
since 03/27/25

Most Recent Stories

More News
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

OMCL : 32.75 (-6.96%)
PODD : 208.22 (-4.53%)
ALGN : 166.38 (-6.17%)
DXCM : 62.25 (-5.81%)
QDEL : 14.78 (-5.26%)
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Headwinds

2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Headwinds

VEEV : 172.59 (-3.19%)
NVR : 6,450.76 (-1.22%)
DXCM : 62.25 (-5.81%)
2 Healthcare Stocks to Target This Week and 1 That Underwhelm

2 Healthcare Stocks to Target This Week and 1 That Underwhelm

HIMS : 19.38 (-7.09%)
NVAX : 8.45 (-5.59%)
DXCM : 62.25 (-5.81%)
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

FTRE : 9.07 (-5.03%)
HUM : 169.09 (-2.96%)
PACB : 1.2600 (-6.67%)
ALHC : 16.62 (-1.71%)
DXCM : 62.25 (-5.81%)
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren’t on insulin therapy 1 , ...

DXCM : 62.25 (-5.81%)
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know

Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know

TECH : 50.95 (-3.32%)
STE : 219.40 (-1.80%)
TFX : 116.22 (+5.19%)
BRKR : 33.72 (-4.58%)
DXCM : 62.25 (-5.81%)
Is DexCom Stock Underperforming the Nasdaq?

DexCom has underperformed the Nasdaq Composite over the past year, yet analysts remain highly optimistic about the stock’s future.

$NASX : 20,948.36 (-2.15%)
STE : 219.40 (-1.80%)
DXCM : 62.25 (-5.81%)
1 Nasdaq 100 Stock with Impressive Fundamentals and 2 We Avoid

1 Nasdaq 100 Stock with Impressive Fundamentals and 2 We Avoid

CMCSA : 28.33 (-1.36%)
WBD : 27.07 (unch)
DXCM : 62.25 (-5.81%)
Dexcom Appoints Rick Osterloh to Board of Directors

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Rick Osterloh to its Board of Directors, effective February 26, 2026. Mr. Osterloh is a...

DXCM : 62.25 (-5.81%)
Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47 th Annual Raymond James Institutional Investors Conference on Monday, March...

DXCM : 62.25 (-5.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 68.70
2nd Resistance Point 67.30
1st Resistance Point 64.78
Last Price 62.25
1st Support Level 60.86
2nd Support Level 59.46
3rd Support Level 56.94

See More

52-Week High 89.98
Fibonacci 61.8% 76.28
Fibonacci 50% 72.04
Fibonacci 38.2% 67.81
Last Price 62.25
52-Week Low 54.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.